Low Bone Mineral Density Predicts Incident Heart Failure in Men and Women. The EPIC (European Prospective Investigation Into Cancer and Nutrition)-Norfolk Prospective Study

JACC: Heart Failure

Volumn 2, Issue 4, 2014, Pages 380-389

  Pfister, Roman ^a   Michels, Guido ^a   Sharp, Stephen J ^b   Luben, Robert ^c   Wareham, Nick J ^b   Khaw, Kay Tee ^c  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Bone mineral density; Heart failure; Osteoporosis

Indexed keywords

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; BONE DENSITY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HUMAN; INCIDENCE; MALE; NORMAL HUMAN; OCCUPATION; OSTEOPOROSIS; PHYSICAL ACTIVITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING; SOCIAL CLASS; SYSTOLIC BLOOD PRESSURE; UNITED KINGDOM; COMPLICATION; ECHOGRAPHY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BONE DENSITY; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84905497973     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2014.03.010     Document Type: Article

References (43)

1. McMurray J.J., Adamopoulos S., Anker S.D., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology: developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012, 33:1787-1847.
2. Tavazzi L., Senni M., Metra M., et al. Multicenter prospective observational study on acute and chronic heart failure: one-year follow-up results of IN-HF (Italian Network on Heart Failure) outcome registry. Circ Heart Fail 2013, 6:473-481.
3. Schocken D.D., Benjamin E.J., Fonarow G.C., et al. Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 2008, 117:2544-2565.
4. NIH Consensus Development Panel. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001, 285:785-795.
5. Kanis J.A., McCloskey E.V., Johansson H., et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2013, 24:23-57.
6. Strom O., Borgstrom F., Kanis J.A., et al. Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 2011, 6:59-155.
7. Sennerby U., Melhus H., Gedeborg R., et al. Cardiovascular diseases and risk of hip fracture. JAMA 2009, 302:1666-1673.
8. van D.S., Majumdar S.R., Bakal J.A., et al. Heart failure is a risk factor for orthopedic fracture: a population-based analysis of 16,294 patients. Circulation 2008, 118:1946-1952.
9. Carbone L., Buzkova P., Fink H.A., et al. Hip fractures and heart failure: findings from the Cardiovascular Health Study. Eur Heart J 2010, 31:77-84.
10. Leistner D.M., Seeger F.H., Fischer A., et al. Elevated levels of the mediator of catabolic bone remodeling RANKL in the bone marrow environment link chronic heart failure with osteoporosis. Circ Heart Fail 2012, 5:769-777.
11. Day N., Oakes S., Luben R., et al. EPIC-Norfolk: study design and characteristics of the cohort: European Prospective Investigation of Cancer. Br J Cancer 1999, 80(Suppl 1):95-103.
12. Abbas S., Linseisen J., Rohrmann S., et al. Dietary vitamin D intake and risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition: the EPIC-InterAct study. Eur J Clin Nutr 2014, 68:196-202.
13. Slimani N., Deharveng G., Unwin I., et al. The EPIC nutrient database project (ENDB): a first attempt to standardize nutrient databases across the 10 European countries participating in the EPIC study. Eur J Clin Nutr 2007, 61:1037-1056.
14. Welch A., Camus J., Dalzell N., et al. Broadband ultrasound attenuation (BUA) of the heel bone and its correlates in men and women in the EPIC-Norfolk cohort: a cross-sectional population-based study. Osteoporos Int 2004, 15:217-225.
15. Wareham N.J., Jakes R.W., Rennie K.L., et al. Validity and repeatability of the EPIC-Norfolk Physical Activity Questionnaire. Int J Epidemiol 2002, 31:168-174.
16. Dargie H.J., McMurray J.J. Diagnosis and management of heart failure. BMJ 1994, 308:321-328.
17. Johansson S., Wallander M.A., Ruigomez A., et al. Incidence of newly diagnosed heart failure in UK general practice. Eur J Heart Fail 2001, 3:225-231.
18. Pfister R., Sharp S.J., Luben R., et al. Plasma vitamin C predicts incident heart failure in men and women in European Prospective Investigation into Cancer and Nutrition-Norfolk prospective study. Am Heart J 2011, 162:246-253.
19. Pfister R., Michels G., Wilfred J., et al. Does ICD-10 hospital discharge code I50 identify people with heart failure? A validation study within the EPIC-Norfolk study. Int J Cardiol 2013, 168:4413-4414.
20. White I.R., Royston P., Wood A.M. Multiple imputation using chained equations: issues and guidance for practice. Stat Med 2011, 30:377-399.
21. White I.R., Royston P. Imputing missing covariate values for the Cox model. Stat Med 2009, 28:1982-1998.
22. Leuven E, Sianesi B. PSMATCH2: Stata module to perform full Mahalanobis and propensity score matching, common support graphing, and covariate imbalance testing. Available at: . Version 4.0.6, May 17, 2012. Accessed September 2013. http://ideas.repec.org/c/boc/bocode/s432001.html.
23. Levis S., Theodore G. Summary of AHRQ's comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report. J Manag Care Pharm 2012, 18:S1-S15.
24. Roger V.L., Weston S.A., Redfield M.M., et al. Trends in heart failure incidence and survival in a community-based population. JAMA 2004, 292:344-350.
25. Lim L.S., Fink H.A., Kuskowski M.A., et al. Loop diuretic use and increased rates of hip bone loss in older men: the Osteoporotic Fractures in Men Study. Arch Intern Med 2008, 168:735-740.
26. Thompson B., Towler D.A. Arterial calcification and bone physiology: role of the bone-vascular axis. Nat Rev Endocrinol 2012, 8:529-543.
27. Farhat G.N., Newman A.B., Sutton-Tyrrell K., et al. The association of bone mineral density measures with incident cardiovascular disease in older adults. Osteoporos Int 2007, 18:999-1008.
28. Shen C., Deng J., Zhou R., et al. Relation between bone mineral density, bone loss and the risk of cardiovascular disease in a Chinese cohort. Am J Cardiol 2012, 110:1138-1142.
29. Tanko L.B., Christiansen C., Cox D.A., et al. Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J Bone Miner Res 2005, 20:1912-1920.
30. Lampropoulos C.E., Papaioannou I., D'Cruz D.P. Osteoporosis: a risk factor for cardiovascular disease?. Nat Rev Rheumatol 2012, 8:587-598.
31. Hagstrom E., Ingelsson E., Sundstrom J., et al. Plasma parathyroid hormone and risk of congestive heart failure in the community. Eur J Heart Fail 2010, 12:1186-1192.
32. Liu L., Chen M., Hankins S.R., et al. Serum 25-hydroxyvitamin D concentration and mortality from heart failure and cardiovascular disease, and premature mortality from all-cause in United States adults. Am J Cardiol 2012, 110:834-839.
33. Li Y.C., Kong J., Wei M., et al. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002, 110:229-238.
34. Simpson R.U., Hershey S.H., Nibbelink K.A. Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse. J Steroid Biochem Mol Biol 2007, 103:521-524.
35. Elefteriou F., Ahn J.D., Takeda S., et al. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 2005, 434:514-520.
36. Ueland T., Yndestad A., Oie E., et al. Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure. Circulation 2005, 111:2461-2468.
37. Haider A.W., Larson M.G., Franklin S.S., Levy D. Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med 2003, 138:10-16.
38. Loehr L.R., Rosamond W.D., Poole C., et al. Association of multiple anthropometrics of overweight and obesity with incident heart failure: the Atherosclerosis Risk in Communities study. Circ Heart Fail 2009, 2:18-24.
39. Screening for osteoporosis: U.S. preventive services task force recommendation statement. Ann Intern Med 2011, 154:356-364.
40. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992, 327:685-691. SOLVD Investigators.
41. Moayyeri A., Kaptoge S., Dalzell N., et al. Is QUS or DXA better for predicting the 10-year absolute risk of fracture?. J Bone Miner Res 2009, 24:1319-1325.
42. Moayyeri A., Adams J.E., Adler R.A., et al. Quantitative ultrasound of the heel and fracture risk assessment: an updated meta-analysis. Osteoporos Int 2012, 23:143-153.
43. Khaw K.T., Reeve J., Luben R., et al. Prediction of total and hip fracture risk in men and women by quantitative ultrasound of the calcaneus: EPIC-Norfolk prospective population study. Lancet 2004, 363:197-202.